Journey Advisory Group LLC Has $384,000 Stock Holdings in Agilent Technologies, Inc. $A

Journey Advisory Group LLC trimmed its position in shares of Agilent Technologies, Inc. (NYSE:A) by 85.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,989 shares of the medical research company’s stock after selling 17,634 shares during the period. Journey Advisory Group LLC’s holdings in Agilent Technologies were worth $384,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Resona Asset Management Co. Ltd. boosted its stake in shares of Agilent Technologies by 6.2% during the 2nd quarter. Resona Asset Management Co. Ltd. now owns 98,400 shares of the medical research company’s stock worth $11,631,000 after acquiring an additional 5,767 shares in the last quarter. CCLA Investment Management lifted its holdings in Agilent Technologies by 10.5% in the 3rd quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock worth $131,909,000 after purchasing an additional 97,312 shares during the last quarter. Nuance Investments LLC boosted its position in Agilent Technologies by 13.5% during the second quarter. Nuance Investments LLC now owns 80,698 shares of the medical research company’s stock worth $9,523,000 after purchasing an additional 9,628 shares during the period. Osaic Holdings Inc. grew its holdings in Agilent Technologies by 35.5% during the second quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after purchasing an additional 17,817 shares during the last quarter. Finally, Envestnet Asset Management Inc. raised its position in shares of Agilent Technologies by 3.8% in the third quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after purchasing an additional 22,498 shares during the period.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $122.92 on Friday. The firm has a market capitalization of $34.77 billion, a price-to-earnings ratio of 26.90, a PEG ratio of 3.57 and a beta of 1.30. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $160.27. The business has a fifty day simple moving average of $136.17 and a 200 day simple moving average of $135.75. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. During the same quarter in the previous year, the company earned $1.46 earnings per share. The business’s revenue was up 9.4% compared to the same quarter last year. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be given a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is 22.32%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on A shares. HSBC assumed coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective for the company. Robert W. Baird raised their price target on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. Bank of America raised their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “neutral” rating in a report on Tuesday, November 25th. Finally, Citigroup upped their price target on Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a report on Tuesday, November 25th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $164.50.

Insider Buying and Selling

In other Agilent Technologies news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. The trade was a 8.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.